Host: Mario E. Lacouture, MD <br>


  
    <p>This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized, appropriate agents to improve outcomes for patients with stage IIB-IV resectable melanoma.</p>

Host: Mario E. Lacouture, MD This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized, appropriate agents to improve outcomes for patients with stage IIB-IV resectable melanoma.

Share Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma

Sign up to save your podcasts

Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma

Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma